Terms: = Germ cell tumor AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2 AND Clinical Outcome
10 results:
1. Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
Manneh Kopp RA; Sepúlveda-Sánchez JM; Ruano Y; Toldos O; Pérez Núñez A; Cantero D; Hilario A; Ramos A; de Velasco G; Sánchez-Gómez P; Hernández-Laín A
Clin Transl Oncol; 2019 Oct; 21(10):1413-1423. PubMed ID: 30877636
[TBL] [Abstract] [Full Text] [Related]
2. Treatment outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal tumors.
Choi SH; Kim SH; Shim KW; Han JW; Choi J; Kim DS; Lyu CJ; Kim JW; Suh CO; Cho J
PLoS One; 2016; 11(4):e0153443. PubMed ID: 27074032
[TBL] [Abstract] [Full Text] [Related]
3. Distant dissemination of mixed low-grade astroblastoma-arteriovenous malformation after initial operation: a case report.
Yao K; Wu B; Xi M; Duan Z; Wang J; Qi X
Int J Clin Exp Pathol; 2015; 8(6):7450-6. PubMed ID: 26261652
[TBL] [Abstract] [Full Text] [Related]
4. olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.
Suzuki A; Nobusawa S; Natsume A; Suzuki H; Kim YH; Yokoo H; Nagaishi M; Ikota H; Nakazawa T; Wakabayashi T; Ohgaki H; Nakazato Y
J Neurooncol; 2014 Nov; 120(2):283-91. PubMed ID: 25085214
[TBL] [Abstract] [Full Text] [Related]
5. Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
Beyeler S; Joly S; Fries M; Obermair FJ; Burn F; Mehmood R; Tabatabai G; Raineteau O
Stem Cells; 2014 Oct; 32(10):2583-95. PubMed ID: 24965159
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
Motomura K; Natsume A; Watanabe R; Ito I; Kato Y; Momota H; Nishikawa R; Mishima K; Nakasu Y; Abe T; Namba H; Nakazato Y; Tashiro H; Takeuchi I; Mori T; Wakabayashi T
Cancer Sci; 2012 Oct; 103(10):1871-9. PubMed ID: 22747609
[TBL] [Abstract] [Full Text] [Related]
7. Molecular characteristics of glioblastoma with 1p/19q co-deletion.
Mizoguchi M; Yoshimoto K; Ma X; Guan Y; Hata N; Amano T; Nakamizo A; Suzuki SO; Iwaki T; Sasaki T
Brain Tumor Pathol; 2012 Jul; 29(3):148-53. PubMed ID: 22736234
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract] [Full Text] [Related]
9. [Morphological classification of glioblastomas].
Figarella-Branger D; Bouvier C; Moroch J; Michalak S; F Burel-Vandenbos
Neurochirurgie; 2010 Dec; 56(6):459-63. PubMed ID: 20864138
[TBL] [Abstract] [Full Text] [Related]
10. Rosette-forming glioneuronal tumor: report of an unusual case with intraventricular dissemination.
Wang Y; Xiong J; Chu SG; Liu Y; Cheng HX; Wang YF; Zhao Y; Mao Y
Acta Neuropathol; 2009 Dec; 118(6):813-9. PubMed ID: 19585134
[TBL] [Abstract] [Full Text] [Related]
